Ann Tsukamoto

Last updated

Ann Tsukamoto
Born (1952-07-06) July 6, 1952 (age 72)
California, United States
Alma materUniversity of California San Diego
University of California Los Angeles
Scientific career
FieldsStem cell biology
InstitutionsUniversity of California San Francisco
SyStemix, Inc.
StemCells, Inc.

Ann S. Tsukamoto Weissman [1] (born July 6, 1952) is an Asian American stem cell researcher and inventor. [2] [3] In 1991, she co-patented a process that allowed the human stem cell to be isolated and demonstrated their potential in treating patients with metastatic breast cancer. [1]

Tsukamoto’s research and contributions in the medical field have led to groundbreaking advancements in stem cell research, especially in understanding the blood systems of cancer patients. [4] Her work has shown potential treatments for cancers and neurological disorders, for which there were previously thought to be none. [1] [4] [5]

Career

Ann Tsukamoto was born in California on July 6, 1952. [6] She completed her bachelor's degree at the University of California San Diego and her Ph.D in immunology and microbiology at the University of California Los Angeles. [6] [7] [8] Ann did most of her postdoctoral work at the University of California, San Francisco. [7] Here, she worked on the wnt-1 gene and developed a transgenic model for breast cancer. Wnt-1 was later discovered to be a key player in the stem cell self-renewal pathway. [8]

She joined the biotech company SyStemix from 1989 to 1997, [9] where she co-discovered the human hematopoietic stem cell (hHSC) and played a leading role in the launch of the clinical research program for this cell. The purified hHSC was shown to be cancer-free when isolated from the cancer-contaminated hematopoietic mobilized blood of patients with disseminated cancer, and it successfully regenerated the patients' blood-forming system after myeloablative chemotherapy. [8]

Ann joined StemCells Inc. in 1998, where she has held several leadership roles overseeing the isolation and application of human neural and liver stem cells for various diseases. [9] She led the scientific team that discovered the human central nervous system stem cell and identified a second candidate stem cell for the liver. Under her guidance, the human neural stem cell transitioned into early clinical development for all three components of the central nervous system: the brain, spinal cord, and eye. The biological potential and activity of these cells were demonstrated in some patients, mirroring the results observed in preclinical rodent studies. [8]

As of 2017, Tsukamoto is an inventor on seven issued U.S. patents, six of which are related to the human hematopoietic stem cell. [8] By 2021, she had reached a total of 13 patents. [7]

References

  1. 1 2 3 "Introducing the 2023 Alumni Award Honorees". University of California San Diego. 2023. Retrieved June 3, 2024.
  2. ↑ "Ann Tsukamoto". See Jane. April 24, 2019. Archived from the original on June 3, 2023. Retrieved August 7, 2021.
  3. ↑ Baum, C. M.; Weissman, I. L.; Tsukamoto, A. S.; Buckle, A. M.; Peault, B. (April 1, 1992). "Isolation of a candidate human hematopoietic stem-cell population". Proceedings of the National Academy of Sciences. 89 (7): 2804–2808. Bibcode:1992PNAS...89.2804B. doi: 10.1073/pnas.89.7.2804 . PMC   48751 . PMID   1372992.
  4. 1 2 "BBC 100 Women: Nine things you didn't know were invented by women". BBC. September 4, 2017. Retrieved June 3, 2024.
  5. ↑ "Dr. Ann Tsukamoto". Carlson Caspers. Retrieved June 3, 2024.
  6. 1 2 "Frauen sind anders. GENDERMEDIZIN: Männer auch" (PDF). Forum – das Magazin des Medizinischen Dienstes: 28–29. 2022.
  7. 1 2 3 Luong, Julia (May 10, 2021). "Ann Tsukamoto: The Woman Inventor Whose Invention Saved Many". NOVA x Network. Archived from the original on December 5, 2022. Retrieved December 5, 2022.
  8. 1 2 3 4 5 Forum on Regenerative Medicine (June 16, 2017). Markowitz-Shulman, Ariel; Hammers-Forstag, Erin; Addie, Siobhan; Beachy, Sarah H. (eds.). Exploring the State of the Science in the Field of Regenerative Medicine: Challenges of and Opportunities for Cellular Therapies: Proceedings of a Workshop. Washington, D.C.: National Academies Press. doi:10.17226/24671. ISBN   978-0-309-45508-4. PMID   28301103.
  9. 1 2 BIOS 206 Brief Speaker Biographies (PDF). Stanford University.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.